Brexit And UK Procurement: Be Ready For Day 1
Executive Summary
There are six weeks or less for medtech companies to be ready to operate as well as they can under Brexit – assuming that it will take place at the third time of asking. The new NHS procurement scheme, already in place, is another potentially disruptive concept for UK companies to adapt to.
You may also be interested in...
UK Must Break The Cycle Of Pricing Pressure And Face Up To Medtech Value Needs
The UK Department of Health's new system of medical device procurement for the NHS went live in May. What was the Future Operating Model (FOM) is now simply the "Operating Model." But there are yet to be any tenders under a system that supposedly champions value and total ownership. UK industry wants to believe it, but will it happen? And will Brexit get in the way?
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.